ROLE OF DUAL-TASK COST IN PREDICTING FALL RISK AMONG OLDER ADULTS RECEIVING INSTITUTIONAL CARE
ROLE OF DUAL-TASK COST IN PREDICTING FALL RISK IN OLDER ADULTS RECEIVING INSTITUTIONAL CARE: A CROSS-SECTIONAL CLASSIFICATION MODEL
調査の概要
状態
詳細な説明
研究の種類
入学 (推定)
連絡先と場所
研究連絡先
- 名前:Mine PEKESEN KURTÇA, ASISTANT PROFESSOR, PhD
- 電話番号:+903623121919
- メール:mine.pekesenkurtca@omu.edu.tr
研究場所
-
-
-
Samsun、トルコ(Türkiye)、55270
- ONDOKUZ MAYIS UNIVERSITY, Samsun, Atakum 55270
-
コンタクト:
- MİNE PEKESEN P KURTÇA, PhD
- 電話番号:+903623121919
- メール:mine.pekesenkurtca@omu.edu.tr
-
-
参加基準
適格基準
就学可能な年齢
- 高齢者
健康ボランティアの受け入れ
サンプリング方法
調査対象母集団
説明
Inclusion Criteria:
- Being 65 years of age or older
- Residing in a nursing home or care institution for at least 1 month
- Ability to walk a distance of at least 10 meters
- Ability to ambulate independently with an assistive device (e.g., cane, walker), if needed
- Having a Montreal Cognitive Assessment (MoCA) score of 18 or above
- Ability to understand and execute single- and two-step verbal commands
- Voluntary agreement to participate in the study and providing informed consent
Exclusion Criteria:
- History of stroke or major orthopedic surgery within the past 6 monthsPresence of Parkinson's disease Stage ≥3 (Hoehn & Yahr) or any other neurological condition significantly affecting gait
- Having a MoCA score below 18
- History of fracture within the past 3 months
- Presence of severe pain affecting gait during test administration (Visual Analog Scale [VAS] ≥ 7)
- Uncontrolled hypertension (≥ 180/100 mmHg) or unstable cardiovascular status
- Active vestibular disease or a history of syncope within the past 3 months
- Visual or hearing impairment severe enough to impede test execution
- Inability to walk/ambulate without the physical assistance of another person
研究計画
研究はどのように設計されていますか?
デザインの詳細
この研究は何を測定していますか?
主要な結果の測定
結果測定 |
メジャーの説明 |
時間枠 |
|---|---|---|
|
Clinical Information Form
時間枠:Single assessment (baseline)
|
The following participant information will be recorded using a clinical information form developed by the researcher: Age (years) Sex (male/female) Educational status(illitirate/primare education/secondary education/high school or higher) Length of institutional stay( months and years) Height(cm) Weight(kg) Body mass index BMI (kg/m²) Number of chronic diseases and comorbidities Number of daily medications Use of assistive devices |
Single assessment (baseline)
|
|
Fall Assesment
時間枠:Single assessment (baseline)
|
Fall history (Tripping, Slipping, Loss of Balance, Transposition) Fall History Questionnaire A fall will be defined as an event which results in an individual coming to rest inadvertently on the ground, floor, or a lower level. In this context, the following information will be recorded: Presence of a fall within the last 12 months (yes/no) Total number of falls within the last 12 months Presence of a fall within the last month (yes/no) Primary cause of the last fall Location of the last fall Injury status resulting from the last fall |
Single assessment (baseline)
|
|
Montreal Cognitive Assessment (MoCA)
時間枠:Single assessment (baseline)
|
This assessment will be utilized to determine whether participants possess the cognitive competence to understand and execute the study protocol.
Individuals with a MoCA score below 18 will be excluded from the study.
|
Single assessment (baseline)
|
|
Timed Up and Go Test (TUG)
時間枠:Single assessment (baseline)
|
This test will be utilized to assess the functional mobility of the participants.
The participant will be instructed to rise from a standard-height chair, walk a distance of 3 meters, turn around, return to the chair, and sit back down.
The duration of the test will be recorded in seconds.
|
Single assessment (baseline)
|
|
Dual-task Timed Up and Go Test (TUG-DT)
時間枠:Single assessment (baseline)
|
This test will be administered to evaluate the dual-task performance of the participants. Participants will be instructed to simultaneously perform a cognitive task during the TUG test. Cognitive Task Animal naming will be utilized as the cognitive task under the dual-task condition. The participant will be asked to name as many animals as possible while walking. All participants will be assigned the same task, and standard verbal instructions will be utilized. |
Single assessment (baseline)
|
|
Dual-Task Cost (DTC)
時間枠:Single assessment (baseline)
|
The dual-task cost will be calculated using the single-task TUG and dual-task TUG durations according to the following formula: DTC (%)"=(TUG_DT-TUG)/TUG×100 An increase in the DTC percentage will indicate greater performance degradation under the dual-task condition.
|
Single assessment (baseline)
|
|
Tinetti Performance-Oriented Mobility Assessment (POMA)
時間枠:Single assessment (baseline)
|
This assessment will be utilized to evaluate the balance and gait performance of the participants. The total Tinetti score will be used to determine the risk of falls. Operational Definition of Fall Risk Fall risk will be operationalized in two ways in the study: As a continuous variable: Total Tinetti score As a binary classification variable: Risk group based on the Tinetti score Classification based on the Tinetti score will be structured as follows: Low fall risk: 25-28 points Increased fall risk: 24 points and below This binary classification will be utilized for the classification model and ROC analysis. |
Single assessment (baseline)
|
|
Falls Efficacy Scale-International (FES-I)
時間枠:Single assessment (baseline)
|
This scale will be utilized to assess the participants' level of fear of falling as a descriptive and secondary variable.
The FES-I score will not serve as a primary variable in the main model; however, it will be reported in descriptive analyses and secondary analyses as required.
|
Single assessment (baseline)
|
協力者と研究者
スポンサー
研究記録日
主要日程の研究
研究開始 (推定)
一次修了 (推定)
研究の完了 (推定)
試験登録日
最初に提出
QC基準を満たした最初の提出物
最初の投稿 (実際)
学習記録の更新
投稿された最後の更新 (実際)
QC基準を満たした最後の更新が送信されました
最終確認日
詳しくは
本研究に関する用語
その他の研究ID番号
- 2026/276
個々の参加者データ (IPD) の計画
個々の参加者データ (IPD) を共有する予定はありますか?
医薬品およびデバイス情報、研究文書
米国FDA規制医薬品の研究
米国FDA規制機器製品の研究
この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。